A share price of Sana Biotechnology Inc [SANA] is currently trading at $4.18, up 2.96%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SANA shares have gain 31.03% over the last week, with a monthly amount glided 43.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Citizens JMP upgraded its rating to Mkt Outperform on March 18, 2025, and kept the price target unchanged to $5. On March 14, 2025, Jefferies initiated with a Buy rating and assigned a price target of $7 on the stock. TD Cowen upgraded its rating to a Buy. JMP Securities downgraded its rating to a Mkt Perform. Rodman & Renshaw started tracking with a Buy rating for this stock on June 26, 2024, and assigned it a price target of $16. In a note dated January 16, 2024, H.C. Wainwright upgraded an Buy rating on this stock but restated the target price of $12.
Sana Biotechnology Inc experienced fluctuations in its stock price throughout the past year between $1.26 and $7.40. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $4.18 at the most recent close of the market. An investor can expect a potential return of 91.39% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -0.76 and Total Capital is -0.52. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.01 points at the first support level, and at 3.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.34, and for the 2nd resistance point, it is at 4.49.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sana Biotechnology Inc [NASDAQ:SANA] is 3.40. Also, the Quick Ratio is 3.40, while the Cash Ratio stands at 2.9.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Feb 18 ’25 when 75000.0 shares were purchased. Officer, CHRISTIAN HORDO & KATHARINE HO completed a deal on Jan 16 ’25 to buy 75000.0 shares. Meanwhile, See Remark 1 FMR LLC sold 0.29 million shares on Jan 08 ’25.
